Navigate this market better. Subscribe for FREE stock alerts and information.

Monday, September 15, 2014

Danaher to purchase Nobel Biocare for $2.2 bln, (NYSE: DHR)

U.S. healthcare group Danaher Corp is to purchase Switzerland's Nobel Biocare Holding AG for an agreed $2.2 billion to become the world's biggest player in a dental implants market benefiting from a recovering global economy.Danaher said on Monday it would pay 17.10 Swiss francs per Nobel Biocare share in cash, about 23 percent above Nobel Biocare's closing price on July 28, the day before the Swiss firm said it was in talks with potential buyers.However, Nobel Biocare shares fell as much as 6 percent after analysts had predicted the company could fetch over 20 francs per share."From my side, it doesn't fill me with that much enthusiasm. But I don't expect there will be a second bid," Sebastien Buch, a portfolio manager at Union Investment which owns roughly 3 percent of Nobel Biocare's shares, told Reuters.

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. Shares of DHR fell by 0.52% or $-0.4/share to $76.88. In the past year, the shares have traded as low as $66.83 and as high as $81.14. On average, 2825900 shares of DHR exchange hands on a given day and today's volume is recorded at 1914701.